BIOMAT Database Logo BIOMAT Database Logo

Suggested management of e-cigarette or vaping product use associated lung injury (EVALI). 2020

René Hage, and Macé M Schuurmans
Division of Pulmonology, University Hospital Zurich and Medical Faculty, University of Zurich, Zurich, Switzerland.

UI MeSH Term Description Entries

Related Publications

René Hage, and Macé M Schuurmans
Characteristics of E-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) Patients.
November 2020, The Journal of the Arkansas Medical Society,
René Hage, and Macé M Schuurmans
Pathogenesis of E-Cigarette Vaping Product Use-Associated Lung Injury (EVALI).
March 2023, Comprehensive Physiology,
René Hage, and Macé M Schuurmans
E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI) Without Respiratory Symptoms.
May 2020, Pediatrics,
René Hage, and Macé M Schuurmans
EVALI - E-Cigarette or Vaping Product Use-Associated Lung Injury: A Case Report.
February 2021, Cureus,
René Hage, and Macé M Schuurmans
E-cigarette or vaping product use-associated lung injury (EVALI): a cautionary tale.
August 2020, The Medical journal of Australia,
René Hage, and Macé M Schuurmans
E-cigarette or vaping product use associated lung injury, (EVALI) - A diagnosis of exclusion.
January 2020, Respiratory medicine case reports,
René Hage, and Macé M Schuurmans
E-cigarette or vaping product use-associated lung injury (EVALI) masquerading as COVID-19.
July 2021, BMJ case reports,
René Hage, and Macé M Schuurmans
Chemical Constituents Involved in E-Cigarette, or Vaping Product Use-Associated Lung Injury (EVALI).
April 2020, Toxics,
René Hage, and Macé M Schuurmans
E-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) Mimicking COVID-19 Disease.
January 2020, Case reports in pulmonology,
René Hage, and Macé M Schuurmans
Reduced plasma phosphatidylethanolamines in e-cigarette, or vaping, product use-associated lung injury (EVALI).
May 2022, Pediatric pulmonology,
Copied contents to your clipboard!